Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Forsyth

Showing results (341-350 of 406) with videos related to

Pageof 41
Sort By:
Journal of the National Cancer Institute|June 21, 2001
Reovirus as an oncolytic agent against experimental human malignant gliomasM E Wilcox, W Yang, D Senger, et al.
British Journal of Cancer|December 24, 2010
Attenuated reovirus displays oncolysis with reduced host toxicityM Kim, K A Garant, N I zur Nieden, et al.
Journal of the National Cancer Institute|November 2, 2006
Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomasXueQing Lun, Donna L Senger, Tommy Alain, et al.
Clinical Lung Cancer|May 8, 2024
Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy AloneMatthew N Mills, Akihiro Uno, Pinxue Li, et al.
Cancer|April 2, 2011
A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomasWilliam T Couldwell, Amy A Surnock, Alfonso J Tobia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamideXue Qing Lun, Ji-Hyun Jang, Nan Tang, et al.
Cancer Causes & Control : CCC|September 3, 2013
Toenail iron, genetic determinants of iron status, and the risk of gliomaGabriella M Anic, Melissa H Madden, Reid C Thompson, et al.
European Journal of Epidemiology|February 20, 2016
Analgesic use and the risk of primary adult brain tumorKathleen M Egan, Louis B Nabors, Zachary J Thompson, et al.
British Journal of Cancer|April 17, 1999
Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomasP A Forsyth, H Wong, T D Laing, et al.
Journal of Neuro-Oncology|April 5, 2014
Reproductive factors and risk of primary brain tumors in womenGabriella M Anic, Melissa H Madden, L Burton Nabors, et al.
Pageof 41

Showing results (341-350 of 406) with videos related to

Sort By:
Pageof 41
Journal of the National Cancer Institute|June 21, 2001
Reovirus as an oncolytic agent against experimental human malignant gliomasM E Wilcox, W Yang, D Senger, et al.
British Journal of Cancer|December 24, 2010
Attenuated reovirus displays oncolysis with reduced host toxicityM Kim, K A Garant, N I zur Nieden, et al.
Journal of the National Cancer Institute|November 2, 2006
Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomasXueQing Lun, Donna L Senger, Tommy Alain, et al.
Clinical Lung Cancer|May 8, 2024
Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy AloneMatthew N Mills, Akihiro Uno, Pinxue Li, et al.
Cancer|April 2, 2011
A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomasWilliam T Couldwell, Amy A Surnock, Alfonso J Tobia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamideXue Qing Lun, Ji-Hyun Jang, Nan Tang, et al.
Cancer Causes & Control : CCC|September 3, 2013
Toenail iron, genetic determinants of iron status, and the risk of gliomaGabriella M Anic, Melissa H Madden, Reid C Thompson, et al.
European Journal of Epidemiology|February 20, 2016
Analgesic use and the risk of primary adult brain tumorKathleen M Egan, Louis B Nabors, Zachary J Thompson, et al.
British Journal of Cancer|April 17, 1999
Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomasP A Forsyth, H Wong, T D Laing, et al.
Journal of Neuro-Oncology|April 5, 2014
Reproductive factors and risk of primary brain tumors in womenGabriella M Anic, Melissa H Madden, L Burton Nabors, et al.
Pageof 41